Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG). (Q33501677)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG). |
scientific article |
Statements
1 reference
Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG). (English)
1 reference
Davidson A
1 reference
Gowing R
1 reference
Lowis S
1 reference
Newell D
1 reference
Lewis I
1 reference
Dicks-Mireaux C
1 reference
Pinkerton CR
1 reference
1 October 1997
1 reference
1 reference
1816-1822
1 reference
Identifiers
1 reference
1 reference